| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
3 companies
Flagship Ventures Fund Iv, L.P. is a 10% Owner at Syros Pharmaceuticals, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 2 buys and 24 sells.
Estimated insider holdings value: $529 based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 23, 2016 | CARM Carisma Therapeutics Inc. | 10% Owner | Sell | 443,422 | $3.16 | $1,403,297.71 | -14.8% | |
| Sep 21, 2016 | CARM Carisma Therapeutics Inc. | 10% Owner | Sell | 386,340 | $3.69 | $1,425,096.88 | -9.6% | |
| Sep 15, 2016 | CARM Carisma Therapeutics Inc. | 10% Owner | Sell | 46,692 | $4.18 | $195,118.94 | -1.7% | |
| Sep 7, 2016 | CARM Carisma Therapeutics Inc. | 10% Owner | Sell | 129,497 | $4.54 | $588,323.87 | -1.9% | |
| Jul 6, 2016 | SYRS Syros Pharmaceuticals, Inc. | 10% Owner | Buy | 400,000 | $12.50 | $5,000,000.00 | +9.5% |